Detailing Reports. 52 TABLE OF CONTENTS (continued) Page 5.10 Training .......................................................................... 52 5.11 Commercialization in the ROW ...................................................... 53
Detailing Reports. On a periodic basis (to be agreed upon) each Party will provide to the other Party a comprehensive detailing report, including, for example: number of primary and secondary details, the use of sample packs, and such other details concerning frequency and other similar detailing data, including coverage by specialty, number of group details, as may be mutually agreed upon.
Detailing Reports. Each Party shall provide the other Party and the CSC with a report as soon as practicable but in no event later than forty-five (45) days following the end of each Quarter during the Co-Promotion Term setting forth, in such detail and form as the Parties shall agree, the number of Details made by such Party's Sales Representatives of Products in the US Territory during such Quarter (each, a "Detailing Report"), provided, however, that the Detailing Report for the fourth such Quarter in each Year shall be cumulative and reflect the number of Details made by such Party's respective Sales Representatives in the US Territory during such Year. Eyetech covenants that it shall develop an internal system for the purpose of reporting the number of Details of its Sales Representatives, and that it shall have such system implemented by the time it begins Detailing the Products.
Detailing Reports. (a) For information purposes, each Party shall, at country level, provide the other Party with current reports giving detailed information on [*]. Such Detailing reports and any other relevant sales force information related to such Antibody Product shall be provided to the other Party [*].
(b) No later than forty-five (45) days after the conclusion of each Calendar Quarter after First Commercial Sale of an Antibody Product in each country, each Party shall submit to the other Party a report, based upon such Party’s internal Detailing report data, setting forth the [*] or otherwise as required by the Country Plan. Except as set forth in Article 5.16(c) below, for purposes of this Agreement the number of Details and Position of Detail for an Antibody Product performed by the first Party for a given Calendar Quarter shall be based on such first Party’s internal Detailing report data.
(c) Each Party agrees, if requested by the other Party, to make available to independent accountants nominated by the other Party (subject to the approval of the Party receiving the request, such approval not to be unreasonably withheld or delayed), upon reasonable advance notice, such books and records necessary to verify the accuracy of such report in respect of any Calendar Quarter ending not more than [*] prior to the date of such request. Upon expiration of [*] following the end of any Contract Year, the report reflecting such Party’s Details for such Antibody Product for such Contract Year shall be binding on the other Party, and such Party shall be released from any liability or accountability to the other Party with respect to the number of Details given during such Contract Year unless prior to such expiration the other Party has notified the first Party of an issue regarding such audit report (arising from such inspection) pursuant to this Article 5.16(c).
(i) If, after an audit, the other Party has a good faith concern with the accuracy of the [*] of Details reflected by the first Party’s internal Detailing report data, based on the other Party’s assessment of such data when compared to available Third Party audit data, sampling data (if applicable) or other relevant data relating to the first Party’s Detailing of such Antibody Product, then the other Party shall so advise the first Party of such concern, and promptly thereafter the other Party and the first Party’s representatives shall consider in good faith whether the [*] of Details reflected by the first Party’s ...
Detailing Reports. Each Party shall keep complete and accurate records of all Details performed by its sales force with respect to the Shared Product in the U.S. Within [**] days following the end of each Calendar Quarter, each Party shall provide the JMC and the JSC with a report setting forth, in such detail and form as the JSC shall require (the “Internal Detailing Report”), based upon each Party’s internal Detailing reporting system, the total number of Details actually performed by such Party, segmented by physician specialty of the Target Audience during the immediately preceding Calendar Quarter. The Parties will, if reasonably necessary, cooperate through the JMC to establish compatible Detail reporting and tracking mechanisms for Detailing the Shared Product to facilitate communication and coordination of the Detailing efforts between the Parties.
Detailing Reports. Each Party shall provide the other Party with a report as soon as practicable but in no event later than forty-five (45) days following the end of each month setting forth, in such detail and form as the Parties shall agree, the number of Details made and the amount of Samples distributed by such Party's respective Sales Representatives in the United States during such month, provided, that the report for the final month in each calendar year shall be cumulative and reflect the number of Details made and Samples distributed by such Party's respective Sales Representatives in the United States during such calendar year.
Detailing Reports. If Mersana exercises its Co-Promotion Right in accordance with Section 9.2.1 (Exercise of Co-Promotion Right), then, within [**] following the end of each [**] occurring during the Co-Promotion Term following the approval of the initial Detailing Plan by the JSC pursuant to Section 9.2.2 (Detailing Plan), each Party shall prepare and deliver to the JCC a written report summarizing, in a format and with a level of detail to be agreed by the JCC, the material Detailing activities conducted by or on behalf of such Party with respect to the Licensed Products under the Detailing Plan in the Shared Territory during such [**], including identifying any issues or circumstances of which it is aware that may prevent or adversely affect in a material manner its future performance of activities assigned to it under the then-current Detailing Plan or otherwise materially adversely affect the Exploitation of the Licensed Compound or any Licensed Product (each, a “Detailing Report”).
Detailing Reports. Each party shall provide to the other party a report of the number of Details carried out by its representatives during each Agreement Quarter. Reports shall be delivered to the other party within six weeks of the end of the applicable Agreement Quarter.
Detailing Reports. Each Party shall keep complete and accurate records of all Details performed by its sales force in Co-Promoting in the United States. Within forty (40) days following the end of each Calendar Quarter, each Party shall provide the JCC with a report setting forth, in such detail and form as the JCC shall require (the “Internal Detailing Report”), based upon each Party’s internal Detailing reporting system, the total number of Details, Primary Details and Secondary Details actually performed by such Party, segmented by physician specialty of the Target [***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Audience during the immediately preceding Calendar Quarter. The Parties will cooperate through the JCC to establish compatible Detail reporting and tracking mechanisms for the Co-Promotion of the Product to allow for communication of the Detailing efforts between the Parties.
Detailing Reports. Within thirty (30) days following the end of each Calendar Quarter, each Party shall provide the PT with a report, in such detail and form as the PT shall require (the "Internal Detailing Report"), based upon such Party's internal Call reporting and Detailing auditing system, setting forth the total number of Details actually performed by such Party in the United States, including information as to whether each Call presented the Product as a Primary Detail or a Secondary Detail, segmented by specialty of the Target Prescribers during the immediately preceding Calendar Quarter.
